GlaxoSmithKline Pharmaceuticals Ukraine LLC (GSK Ukraine) seeks to register new vaccines in Ukraine to remove a temporary shortage of pertussis vaccines.

"GSK Ukraine many times in 2014-2015 informed Ukraine's Health Ministry on the situation with supplies. GSK Ukraine plans to register new vaccines, which will be able to improve the situation with supplies of vaccines containing pertussis components, in Ukraine," the company told Interfax-Ukraine.

The company said that there is shortage of pertussis vaccines because governments have introduced new government-sponsored pertussis vaccination programs.

"Additionally, the vaccination figures under the current government-sponsored programs in different countries are growing. The increased global demand for vaccines and the restricted production capacity caused the projected temporary restriction of supplies of some vaccines made by GlaxoSmithKline Biologicals S.A. containing pertussis component to Ukraine," GSK Ukraine said.

The company said that GSK is taking part in tenders announced by authorized international organizations, although the names of the medicines cannot be disclosed before the tenders are finished.